XML 37 R106.htm IDEA: XBRL DOCUMENT v3.20.1
Capital Stock (Stock Options Activity) (Details)
$ / shares in Units, shares in Millions, $ in Millions
12 Months Ended
Mar. 31, 2020
USD ($)
$ / shares
shares
Stock Options, Equity-Settled SARs and Cash-Settled SARs | Class A Voting Common Shares  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Outstanding, beginning of period (in shares) 8.4
Granted (in shares) 0.0
Exercised (in shares) 0.0
Forfeited or expired (in shares) (1.2)
Outstanding, end of period (in shares) 7.2
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]  
Outstanding, Beginning of Period, Weighted Average Exercise Price (in usd per share) | $ / shares $ 26.70
Granted, Weighted Average Exercise Price (in usd per share) | $ / shares 0
Exercised, Weighted Average Exercise Price (in usd per share) | $ / shares 0
Forfeited or expired, Weighted Average Exercise Price (in usd per share) | $ / shares 29.58
Outstanding, End of Period, Weighted Average Exercise Price (in usd per share) | $ / shares $ 26.21
Outstanding, Weighted Average Remaining Contractual Term (in years) 4 years 3 months 7 days
Outstanding, Aggregate Intrinsic Value | $ $ 0.0
Outstanding, vested or expected to vest (in shares) 7.2
Outstanding, vested or expected to vest, Weighted Average Exercise Price (in usd per share) | $ / shares $ 26.21
Outstanding, vested or expected to vest, Weighted Average Remaining Contractual Term In Years 4 years 3 months 7 days
Outstanding, vested or expected to vest, Aggregate Intrinsic Value | $ $ 0.0
Exercisable (in shares) 5.7
Exercisable, Weighted Average Exercise Price (in usd per share) | $ / shares $ 27.15
Exercisable, Weighted Average Remaining Contractual Term In Years 3 years 9 months 14 days
Exercisable, Aggregate Intrinsic Value | $ $ 0.0
Stock Options, Equity-Settled SARs and Cash-Settled SARs | Class B Non-Voting Common Shares  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Outstanding, beginning of period (in shares) 26.2
Granted (in shares) 7.8
Exercised (in shares) 0.2
Forfeited or expired (in shares) (5.3)
Outstanding, end of period (in shares) 28.5
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]  
Outstanding, Beginning of Period, Weighted Average Exercise Price (in usd per share) | $ / shares $ 20.72
Granted, Weighted Average Exercise Price (in usd per share) | $ / shares 12.52
Exercised, Weighted Average Exercise Price (in usd per share) | $ / shares 9.99
Forfeited or expired, Weighted Average Exercise Price (in usd per share) | $ / shares 17.72
Outstanding, End of Period, Weighted Average Exercise Price (in usd per share) | $ / shares $ 19.03
Outstanding, Weighted Average Remaining Contractual Term (in years) 4 years 9 months 14 days
Outstanding, Aggregate Intrinsic Value | $ $ 0.1
Outstanding, vested or expected to vest (in shares) 28.1
Outstanding, vested or expected to vest, Weighted Average Exercise Price (in usd per share) | $ / shares $ 19.11
Outstanding, vested or expected to vest, Weighted Average Remaining Contractual Term In Years 4 years 8 months 19 days
Outstanding, vested or expected to vest, Aggregate Intrinsic Value | $ $ 0.1
Exercisable (in shares) 17.3
Exercisable, Weighted Average Exercise Price (in usd per share) | $ / shares $ 21.06
Exercisable, Weighted Average Remaining Contractual Term In Years 2 years 9 months 3 days
Exercisable, Aggregate Intrinsic Value | $ $ 0.0
Cash-Settled SARs | Class B Non-Voting Common Shares  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Granted (in shares) 3.3